Complete Conference Management 30th Annual Heart Failure 2026
Complete Conference Management 30th Annual Heart Failure 2026
Couldn't load pickup availability
Complete Conference Management 30th Annual Heart Failure 2026
Complete Conference Management 30th Annual Heart Failure 2026
Advanced Heart Failure, Cardiomyopathy & Contemporary Cardiovascular Therapy Update
The Complete Conference Management 30th Annual Heart Failure 2026 program provides a comprehensive review of contemporary heart failure management, focusing on the latest advances in prevention, diagnosis, pharmacologic therapy, device-based interventions, and long-term patient care.
Celebrating its 30th year, this highly regarded symposium brings together leading cardiovascular experts to discuss evidence-based strategies for managing acute and chronic heart failure across a broad spectrum of clinical presentations. The program emphasizes practical clinical decision-making, guideline-directed medical therapy (GDMT), emerging treatment options, and multidisciplinary approaches designed to improve patient outcomes.
Through expert-led lectures, clinical updates, and interactive discussions, participants gain valuable insight into current and future approaches to heart failure management, including cardiomyopathies, valvular heart disease, pulmonary hypertension, cardiorenal syndromes, and advanced heart failure therapies.
Course Features
• 8 Video Lectures
• 8 VTT Subtitle Files
• 29 PDF Presentations
• Total Size: 5.99 GB
• Expert Faculty Presentations
• Evidence-Based Clinical Updates
• Interactive Panel Discussions
• Hybrid Conference Format
• Advanced Heart Failure Education
Target Audience
This course is ideal for:
• Cardiologists
• Advanced Heart Failure Specialists
• Internists
• Primary Care Physicians
• Intensivists
• Pharmacists
• Nurse Practitioners
• Nurses
• Healthcare Professionals Involved in Cardiovascular Care
It is particularly valuable for clinicians seeking:
• Guideline-Directed Medical Therapy (GDMT) Updates
• Advanced Heart Failure Management
• Cardiogenic Shock Education
• Cardiomyopathy Treatment Strategies
• Heart Failure Pharmacotherapy Updates
• Valvular Heart Disease Interventions
• Cardiorenal Syndrome Management
• Contemporary Cardiovascular Guidelines
Program Overview
Heart failure remains one of the leading causes of cardiovascular morbidity and mortality worldwide. Rapid advances in pharmacologic therapies, device-based treatments, imaging technologies, and precision medicine continue to transform patient care and improve outcomes.
The 30th Annual Heart Failure 2026 symposium provides an extensive review of contemporary approaches to managing patients with heart failure across all stages of disease. The curriculum explores current evidence, emerging therapies, updated guidelines, and challenging clinical scenarios frequently encountered in cardiovascular practice.
Special emphasis is placed on the prevention and treatment of heart failure with reduced ejection fraction (HFrEF), heart failure with preserved ejection fraction (HFpEF), acute decompensated heart failure, cardiogenic shock, and complex cardiomyopathies.
Participants will leave with practical recommendations and evidence-based strategies that can be immediately applied to improve the care of patients with heart failure and related cardiovascular conditions.
Learning Objectives
Upon completion of this activity, participants will be able to:
• Review current hypertension and lipid management guidelines relevant to cardiovascular risk reduction
• Apply contemporary treatment strategies for HFrEF and HFpEF
• Integrate evidence-based pharmacologic therapies into heart failure management
• Manage patients with acute decompensated heart failure
• Evaluate and treat heart failure patients with concurrent kidney disease
• Discuss optimal management of atrial fibrillation in heart failure patients
• Understand catheter-based interventions for valvular heart disease
• Develop treatment strategies for hypertrophic cardiomyopathy and cardiac amyloidosis
• Address obesity-related challenges in heart failure management
• Apply current approaches to pulmonary arterial hypertension
Core Topics Covered
Guideline-Directed Medical Therapy (GDMT)
• Contemporary Heart Failure Guidelines
• HFrEF Management
• HFpEF Management
• Pharmacologic Optimization
• Evidence-Based Treatment Algorithms
Advanced Heart Failure Management
• Acute Decompensated Heart Failure
• Advanced Heart Failure Therapies
• Cardiogenic Shock
• Mechanical Circulatory Support
• Referral Strategies for Advanced Care
Cardiomyopathies & Infiltrative Heart Disease
• Hypertrophic Cardiomyopathy
• Cardiac Amyloidosis
• Genetic Testing & Precision Medicine
• Inherited Cardiovascular Disorders
Heart Failure & Kidney Disease
• Cardiorenal Syndrome
• Renal Protection Strategies
• Integrated Heart-Kidney Management
• Therapeutic Decision-Making
Arrhythmias in Heart Failure
• Atrial Fibrillation Management
• Rhythm Control Strategies
• Anticoagulation Considerations
• Device-Based Therapies
Valvular Heart Disease
• Catheter-Based Valve Interventions
• Structural Heart Disease
• Patient Selection Strategies
• Procedural Advances
Pulmonary Hypertension
• Pulmonary Arterial Hypertension
• Right Heart Failure
• Diagnostic Evaluation
• Contemporary Treatment Approaches
Special Populations
• Obesity & Heart Failure
• Peripartum Cardiomyopathy
• Myocarditis
• Geriatric Heart Failure Care
Prevention & Risk Reduction
• Hypertension Management
• Hyperlipidemia Treatment
• Cardiovascular Prevention Strategies
• Early Detection of Heart Failure
Educational Features
✔ Expert-Led Cardiovascular Education
✔ Comprehensive Heart Failure Updates
✔ Evidence-Based Clinical Recommendations
✔ Advanced Cardiomyopathy Management
✔ Interactive Faculty Discussions
✔ Contemporary Guideline Reviews
✔ Practical Clinical Applications
✔ Immediate Relevance to Daily Practice
Why This Course Stands Out
✔ Celebrating 30 Years of Excellence in Heart Failure Education
✔ Comprehensive Coverage of Acute & Chronic Heart Failure
✔ Strong Focus on Guideline-Directed Medical Therapy
✔ Expert Insights into Complex Cardiovascular Cases
✔ Advanced Cardiomyopathy & Amyloidosis Education
✔ Contemporary Device & Structural Heart Updates
✔ Practical Management Strategies for Real-World Patients
✔ Multidisciplinary Approach to Cardiovascular Care
Clinical & Educational Value
The Complete Conference Management 30th Annual Heart Failure 2026 program delivers an in-depth review of modern heart failure care, combining current guidelines, emerging therapies, advanced diagnostics, and practical management strategies.
By integrating updates in pharmacotherapy, device therapy, cardiomyopathy management, structural heart disease, pulmonary hypertension, and cardiovascular prevention, this course equips clinicians with the knowledge necessary to optimize outcomes for patients with heart failure across diverse clinical settings.
The program is an outstanding educational resource for cardiologists, internists, primary care physicians, and advanced heart failure specialists seeking the latest evidence-based approaches to cardiovascular care.
4. Topics
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
-
Case Discussions
-
Product Theatre Breakfast – Non-CME Navigating Fabry Disease
-
SESSION I
-
SESSION II
-
SESSION III
-
SESSION IV
-
SESSION V
-
SESSION VI
- 11:00am-12:00pm Registration, Coffee, Visit Exhibits
- 12:00-1:00pm Product Theatre Luncheon – Non-CME Evidence – Based Treatment of Recurrent Pericarditis Mariko Harper, MD, MS, FACC Supported by: Kiniksa
- 1:00-1:15pm Coffee Break and Visit Exhibits
- SESSION I
- 1:15-1:25pm Introduction to the 30th Annual Symposium: Heart Failure 2026 – An Update on Therapy Uri Elkayam, MD, FACC
- 1:25-1:45pm Management of the Hospitalized Patients with Decompensated Heart Failure Uri Elkayam, MD, FACC
- 1:45-2:05pm Balancing GDMT and Hyperkalemia Ileana L. Piña, MD
- 2:05-2:25pm Digitoxin in Heart Failure: A Comeback for Digitalis? Tien Ng, PharmD
- 2:25-2:45pm Introducing Finerenone: A New Drug for the Management of Heart Failure and Chronic Kidney Disease Akshay Desai, MD
- 2:45-3:05pm Vericiguat in Heart Failure: When and How to Use It Barry Greenberg, MD
- 3:05-3:25pm The Contemporary Management of HFpEF Akshay Desai, MD
- 3:25-3:40pm Coffee Break and Visit Exhibits
- SESSION II
- 3:40-4:00pm Our Journey with Diuretics: 240 Years, and How Far Have We Come? Marvin Konstam, MD
- 4:00-4:20pm Treating Congestion in Patients with Acute Decompensated Heart Failure: Where Are We Now? Where Are We Going? William Abraham, MD
- 4:20-4:40pm Releasing the Brakes on the Immune System in Cancer: Implications in Myocarditis and Beyond Eric Yang, MD
- 4:40-5:00pm Clinical Experience with the Use of Myosin Inhibitors in the Treatment of Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy Jessica Wang, MD
- 5:00-5:20pm Contemporary Management of Obesity in Patients with Heart Failure Norman Lepor, MD
- 5:20pm Adjourn
- 7:00am Registration Open
- 7:15-7:45am Case Discussion Uri Elkayam, MD and Barry Greenberg, MD
- 7:45-8:45am Product Theatre Breakfast – Non-CME Navigating Fabry Disease Dr. Anjay Rastogi Supported by: Sanofi
- 8:45-9:00am Break and Visit the Exhibits
- SESSION III
- 9:00-9:15am Introduction to Day Two: 30th Annual Symposium: Heart Failure 2026 – An Update on Therapy Uri Elkayam, MD
- 9:15-9:35am GDMT for Chronic HFrEF: How to Maximize the Benefits? Gregg Fonarow, MD
- 9:35-9:55am Cardiogenic Shock: Hemodynamic Classification and Management Rola Khedraki, MD
- 9:55-10:15am Percutaneous Coronary Interventions in Ischemic Cardiomyopathy – Does It Work? Christina Economides, MD
- 10:15-10:35am Bio-Omics in Heart Failure Diagnosis and Therapy Kirkwood Adams, MD
- 10:35-10:55am Break and Visit the Exhibits
- SESSION IV
- 10:55-11:15am Genetic Testing for Cardiomyopathy Josh Hare, MD
- 11:15-11:35am Gene Therapy for Patients with Cardiomyopathy Barry Greenberg, MD
- 11:35-11:55am Stem Cell Therapy for the Management of Myocardial Disease: A Status Report Josh Hare, MD
- 11:55-12:15pm Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy Uri Elkayam, MD
- 12:15-12:35pm Update on the Management of Atrial Fibrillation in Patients with Heart Failure Anil Bhandari, MD
- 12:35-1:35pm Product Theatre Luncheon – Non-CME Pivotal Trial and Cardiac Structure and Function Outcomes With CAMZYOS® in Patients With Symptomatic NYHA Class II-III Obstructive HCM Florian Rader, MD Supported by: Bristol Myers Squibb
- 1:35-1:50pm Break and Visit the Exhibits
- SESSION V
- 1:50-2:20pm KEYNOTE LECTURE 30 Years of Innovation in the Management of Heart Failure: A Perspective Clyde Yancy, MD
- 2:20-2:40pm Bromocriptine in the Management of Peripartum Cardiomyopathy: Pathophysiologic Mechanism and Available Data Uri Elkayam, MD
- 2:40-3:00pm What Is New in Myocarditis: An Update from the ESC 2025 Guidelines Leslie Cooper, MD
- 3:00-3:20pm Pulmonary Hypertension: New Drugs and How to Use Them Thomas Heywood, MD
- 3:20-3:40pm Innovations in Device Therapy for Heart Failure William Abraham, MD
- 3:40-4:00pm Break and Visit Exhibits
- SESSION VI
- 4:00-4:20pm The Use of AI in the Management of Heart Failure Nir Uriel, MD
- 4:20-4:40pm Autonomic Modulation in Heart Failure Treatment: Where Are We and Where Are We Heading? Marvin Konstam, MD
- 4:40-5:00pm LVAD vs Heart Transplantation: A Perspective Nir Uriel, MD
- 5:00-5:20pm Individual Selection of Drug Therapy in Patients with Transthyretin (TTR) Amyloidosis Mazen Hanna, MD
- 5:20pm Adjourn
